NCT01010789View on ClinicalTrials.gov

Armodafinil in Binge Eating Disorder (BED)

PHASE3CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

November 30, 2014

Study Completion Date

May 31, 2015

Conditions

Binge Eating DisorderOverweightObese

Interventions

DRUG

Armodafinil

flexible dose 150-250mg/day

DRUG

Armodafinil

150-250mg/day; flexible dose

DRUG

Matching placebo

Placebo comparator

Trial Locations (1)

Unknown

Lindner Center of HOPE, Mason

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Cephalon

INDUSTRY

collaborator

University of Cincinnati

OTHER

lead

Lindner Center of HOPE

OTHER